知镜 Cognispect · 医学文献与研究工作台

Nanodrug Delivery Systems for Lower Respiratory Infections: Pulmonary Targeting, Anti-Infective Applications, and Translational Challenges.

Zhu WB, Liu T, Cheng GL, Xu KQ, Fang JM, Ma Y, Lu JX, Xue Y, Xu LL.
International journal of nanomedicine · 2026-09-02 · PMID 42703524

文献摘要

Lower respiratory infections (LRIs) remain a leading cause of global morbidity and mortality, particularly among vulnerable populations such as children and the elderly. Although conventional antimicrobial therapies remain central to clinical management, their efficacy is often limited by poor pulmonary bioavailability, systemic toxicity, inadequate penetration of mucus or biofilms, and the rapid emergence of drug-resistant pathogens. Nanodrug delivery systems (NDDS) provide a promising strategy to address these limitations by improving pulmonary deposition, protecting labile therapeutics, enabling controlled release, and supporting disease-site targeting. In this review, we systematically summarize recent advances in NDDS for LRIs, with emphasis on the design principles and functional characteristics of lipid-based, polymeric, inorganic, and hybrid nanocarriers. We further connect these platforms with disease-specific therapeutic challenges in bacterial pneumonia, tuberculosis, viral infections, and fungal pneumonia, highlighting how carrier composition, surface engineering, and release behavior can be adapted to mucus barriers, biofilms, intracellular pathogen niches, and inflammatory microenvironments. Importantly, we discuss emerging trends, including bioinspired nanocarriers, stimuli-responsive systems, and multifunctional theranostic platforms, while also evaluating key translational barriers such as biosafety, immunogenicity, reproducible manufacturing, and regulatory standardization.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。